Immunohistochemical Detection of the CXCR4 Expression in Tumor Tissue Using the Fluorescent Peptide Antagonist Ac-TZ14011-FITC

Pathology is fundamental in grading, staging, and treatment planning of malignancies. One relatively novel biomarker that may become more important in therapy and diagnostics is the chemokine receptor 4 (CXCR4). Ac-TZ14011 peptide derivatives, functionalized with a radiolabel, can be used for molecu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: van den Berg, Nynke S, Buckle, Tessa, Kuil, Joeri, Wesseling, Jelle, van Leeuwen, Fijs WB
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press Inc. 2011
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3140011/
https://ncbi.nlm.nih.gov/pubmed/21804919
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia